Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Wexler

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1993
Susceptibility testing of anaerobic bacteria--the state of the artH M Wexler
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 1997
Pore-forming molecules in gram-negative anaerobic bacteriaH M Wexler
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|April 9, 1998
Anaerobic susceptibility testing: where are we and where do we go from here?H M Wexler
Clinical Microbiology Reviews|October 1, 1991
Susceptibility testing of anaerobic bacteria: myth, magic, or method?H M Wexler
The Journal of Antimicrobial Chemotherapy|July 1, 1990
Alterations to the penicillin-binding proteins in the Bacteroides fragilis group: a mechanism for non-beta-lactamase mediated cefoxitin resistanceH M Wexler, S Halebian
Antimicrobial Agents and Chemotherapy|May 1, 1988
Therapeutic implications of bacteriologic findings in mixed aerobic-anaerobic infectionsS M Finegold, H M Wexler
Hospital Practice (Office Ed.)|October 1, 1990
Effects of differences in media and methods on MIC values for anaerobesH M Wexler, S M Finegold
European Journal of Clinical Microbiology|August 1, 1987
Comparative in vitro activity of the new macrolide A-56268 against anaerobic bacteriaH M Wexler, S M Finegold
Clinical Therapeutics|January 1, 1990
Media- and method-dependent variation in MIC values of ceftizoxime for clinical isolates of the Bacteroides fragilis groupH M Wexler, S M Finegold
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 1996
In vitro susceptibility of anaerobes to quinolones in the United StatesD W Hecht, H M Wexler
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1993
Susceptibility testing of anaerobic bacteria--the state of the artH M Wexler
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 1997
Pore-forming molecules in gram-negative anaerobic bacteriaH M Wexler
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|April 9, 1998
Anaerobic susceptibility testing: where are we and where do we go from here?H M Wexler
Clinical Microbiology Reviews|October 1, 1991
Susceptibility testing of anaerobic bacteria: myth, magic, or method?H M Wexler
The Journal of Antimicrobial Chemotherapy|July 1, 1990
Alterations to the penicillin-binding proteins in the Bacteroides fragilis group: a mechanism for non-beta-lactamase mediated cefoxitin resistanceH M Wexler, S Halebian
Antimicrobial Agents and Chemotherapy|May 1, 1988
Therapeutic implications of bacteriologic findings in mixed aerobic-anaerobic infectionsS M Finegold, H M Wexler
Hospital Practice (Office Ed.)|October 1, 1990
Effects of differences in media and methods on MIC values for anaerobesH M Wexler, S M Finegold
European Journal of Clinical Microbiology|August 1, 1987
Comparative in vitro activity of the new macrolide A-56268 against anaerobic bacteriaH M Wexler, S M Finegold
Clinical Therapeutics|January 1, 1990
Media- and method-dependent variation in MIC values of ceftizoxime for clinical isolates of the Bacteroides fragilis groupH M Wexler, S M Finegold
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 1996
In vitro susceptibility of anaerobes to quinolones in the United StatesD W Hecht, H M Wexler
Pageof 7